Zoetis Inc. (ZTS)

Zoetis Inc. is a Healthcare company in the S&P 500, with a market capitalization of about $28.9 billion as of October 1, 2026.

Ticker
ZTS · NYSE
Sector
Healthcare
Industry (SIC)
Pharmaceutical Preparations
Market cap
$28.9 billion
Employees
14,500
Headquarters
Parsippany, NJ
Fiscal year end
December 31

About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Financial statements

Nvevo shows Zoetis Inc.'s income statement, balance sheet, cash flow statement and key ratios as reported in its 10-K and 10-Q filings with the SEC, annually and quarterly, alongside price history, recent news and fair value models.

Other Healthcare companies

Research another company · Market map · Stock screener · Compare companies